Ardelyx | ARDX - Current Liabilities

Stock Price
7.60
Daily Change
-0.19 -2.49%
Monthly
24.73%
Yearly
37.61%
Q1 Forecast
7.45

Ardelyx reported $83.39M in Current Liabilities for its fiscal quarter ending in September of 2025.





Current Liabilities Change Date
Abbott USD 14.58B 1.14B Sep/2025
Amgen USD 21.79B 1.32B Sep/2025
Ardelyx USD 83.39M 1.67M Sep/2025
aTyr Pharma USD 15.68M 148K Sep/2025
Corcept Therapeutics USD 172.26M 27.6M Sep/2025
Sanofi EUR 28.35B 9.32B Dec/2025
TG Therapeutics USD 156.81M 15.08M Sep/2025
United Therapeutics USD 546.3M 19.2M Sep/2025